Literature DB >> 31253680

A Vibrating Mesh Nebulizer as an Alternative to the Collison Three-Jet Nebulizer for Infectious Disease Aerobiology.

Jennifer D Bowling1, Katherine J O'Malley1, William B Klimstra1,2, Amy L Hartman1,3, Douglas S Reed4,2.   

Abstract

Experimental infection of animals with aerosols containing pathogenic agents is essential for an understanding of the natural history and pathogenesis of infectious disease as well as evaluation of potential treatments. We evaluated whether the Aeroneb nebulizer, a vibrating mesh nebulizer, would serve as an alternative to the Collison nebulizer, the "gold standard" for generating infectious bioaerosols. While the Collison possesses desirable properties that have contributed to its longevity in infectious disease aerobiology, concerns have lingered about the liquid volume and concentration of the infectious agent required to cause disease and the damage that jet nebulization causes to the agent. Fluorescein salt was added to the nebulizer contents to assess pathogen loss during aerosolization. Relative to fluorescein salt, loss of influenza virus during aerosolization was worse with the Collison than with the Aeroneb. Four other viruses also had superior aerosol performance with the Aeroneb. The Aeroneb did not improve the aerosol performance for a vegetative bacterium, Francisella tularensis Environmental parameters collected during the aerosol challenges indicated that the Aeroneb generated a higher relative humidity in exposure chambers while not affecting other environmental parameters. The aerosol mass median aerodynamic diameter (MMAD) was generally larger and more disperse for aerosols generated by the Aeroneb than what is seen with the Collison, but ≥80% of particles were within the range that would reach the lower respiratory tract and alveolar regions. The improved aerosol performance and generated particle size range suggest that for viral pathogens, the Aeroneb is a suitable alternative to the Collison three-jet nebulizer for use in experimental infection of animals.IMPORTANCE Respiratory infection by pathogens via aerosol remains a major concern for both natural disease transmission as well as intentional release of biological weapons. Critical to understanding the disease course and pathogenesis of inhaled pathogens are studies in animal models conducted under tightly controlled experimental settings, including the inhaled dose. The route of administration, particle size, and dose can affect disease progression and outcome. Damage to or loss of pathogens during aerosolization could increase the dose required to cause disease and could stimulate innate immune responses, altering outcome. Aerosol generators that reduce pathogen loss would be ideal. This study compares two aerosol generators to determine which is superior for animal studies. Aerosol research methods and equipment need to be well characterized to optimize the development of animal models for respiratory pathogens, including bioterrorism agents. This information will be critical for pivotal efficacy studies in animals to evaluate potential vaccines or treatments against these agents.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  aerosol; bacteriology; infectious disease; respiratory pathogens; virology

Mesh:

Substances:

Year:  2019        PMID: 31253680      PMCID: PMC6696971          DOI: 10.1128/AEM.00747-19

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  18 in total

1.  Viability and infectivity of microorganisms in experimental airborne infection.

Authors:  R J GOODLOW; F A LEONARD
Journal:  Bacteriol Rev       Date:  1961-09

Review 2.  Aerobiology and inhalation exposure to biological select agents and toxins.

Authors:  C J Roy; D S Reed; J A Hutt
Journal:  Vet Pathol       Date:  2010-08-03       Impact factor: 2.221

3.  Performance of the vibrating membrane aerosol generation device: Aeroneb Micropump Nebulizer.

Authors:  Guifang Zhang; Anand David; Timothy Scott Wiedmann
Journal:  J Aerosol Med       Date:  2007

4.  Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation.

Authors:  Arzu Ari; Orcin Telli Atalay; Robert Harwood; Meryl M Sheard; Essam A Aljamhan; James B Fink
Journal:  Respir Care       Date:  2010-07       Impact factor: 2.258

5.  Sampling port for real-time analysis of bioaerosol in whole body exposure system for animal aerosol model development.

Authors:  Divey Saini; Gregory W Hopkins; Ching-Ju Chen; Sarah A Seay; Eva M Click; Sunhee Lee; Justin M Hartings; Richard Frothingham
Journal:  J Pharmacol Toxicol Methods       Date:  2010-09-16       Impact factor: 1.950

6.  The cell membrane as a major site of damage during aerosolization of Escherichia coli.

Authors:  Richard J Thomas; Daniel Webber; Rebecca Hopkins; Andrew Frost; Thomas Laws; Pramukh N Jayasekera; Timothy Atkins
Journal:  Appl Environ Microbiol       Date:  2010-12-10       Impact factor: 4.792

7.  Comparison of the efficiency of sampling devices for aerosolized Burkholderia pseudomallei.

Authors:  Paul Dabisch; John Yeager; Jamie Kline; Katie Klinedinst; Andrew Welsch; Margaret L Pitt
Journal:  Inhal Toxicol       Date:  2012-04       Impact factor: 2.724

8.  Influence of particle size on the pathology and efficacy of vaccination in a murine model of inhalational anthrax.

Authors:  Richard Thomas; Carwyn Davies; Alejandro Nunez; Stephen Hibbs; Helen Flick-Smith; Lin Eastaugh; Sophie Smither; Amanda Gates; Petra Oyston; Timothy Atkins; Steve Eley
Journal:  J Med Microbiol       Date:  2010-08-26       Impact factor: 2.472

9.  Treatment of influenza infection of mice by using rimantadine hydrochlorides by the aerosol and intraperitoneal routes.

Authors:  E L Stephen; J W Dominik; J B Moe; R O Spertzel; J S Walker
Journal:  Antimicrob Agents Chemother       Date:  1975-08       Impact factor: 5.191

10.  Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus.

Authors:  Jacquelyn M Bales; Diana S Powell; Laura M Bethel; Douglas S Reed; Amy L Hartman
Journal:  Front Cell Infect Microbiol       Date:  2012-08-02       Impact factor: 5.293

View more
  11 in total

1.  Particle Dynamics and Bioaerosol Viability of Aerosolized Bacillus Calmette-Guérin Vaccine Using Jet and Vibrating Mesh Clinical Nebulizers.

Authors:  Rachel K Redmann; Deepak Kaushal; Nadia Golden; Breeanna Threeton; Stephanie Z Killeen; Philip J Kuehl; Chad J Roy
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2021-10-06       Impact factor: 2.849

2.  Long-term persistence of viral RNA and inflammation in the CNS of macaques exposed to aerosolized Venezuelan equine encephalitis virus.

Authors:  Henry Ma; Joseph R Albe; Theron Gilliland; Cynthia M McMillen; Christina L Gardner; Devin A Boyles; Emily L Cottle; Matthew D Dunn; Jeneveve D Lundy; Noah Salama; Katherine J O'Malley; Ivona Pandrea; Tobias Teichert; Stacey Barrick; William B Klimstra; Amy L Hartman; Douglas S Reed
Journal:  PLoS Pathog       Date:  2022-06-13       Impact factor: 7.464

3.  Inherent Heterogeneity of Influenza A Virus Stability following Aerosolization.

Authors:  Jessica A Belser; Joanna A Pulit-Penaloza; Nicole Brock; Hannah M Creager; Kortney M Gustin; Terrence M Tumpey; Taronna R Maines
Journal:  Appl Environ Microbiol       Date:  2022-01-05       Impact factor: 5.005

4.  Utility of Three Nebulizers in Investigating the Infectivity of Airborne Viruses.

Authors:  Sadegh Niazi; Lisa K Philp; Kirsten Spann; Graham R Johnson
Journal:  Appl Environ Microbiol       Date:  2021-07-27       Impact factor: 4.792

5.  Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses.

Authors:  Sham Nambulli; Yufei Xiang; Natasha L Tilston-Lunel; Linda J Rennick; Zhe Sang; William B Klimstra; Douglas S Reed; Nicholas A Crossland; Yi Shi; W Paul Duprex
Journal:  Sci Adv       Date:  2021-05-26       Impact factor: 14.136

6.  Electrocardiography Abnormalities in Macaques after Infection with Encephalitic Alphaviruses.

Authors:  Henry Ma; Jeneveve D Lundy; Katherine J O'Malley; William B Klimstra; Amy L Hartman; Douglas S Reed
Journal:  Pathogens       Date:  2019-11-16

7.  SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts.

Authors:  Amy L Hartman; Sham Nambulli; Cynthia M McMillen; Alexander G White; Natasha Louise Tilston-Lunel; Joseph R Albe; Emily Cottle; Matthew D Dunn; L James Frye; Theron H Gilliland; Emily L Olsen; Katherine J O'Malley; Madeline M Schwarz; Jaime A Tomko; Reagan C Walker; Mengying Xia; Matthew S Hartman; Edwin Klein; Charles A Scanga; JoAnne L Flynn; William B Klimstra; Anita K McElroy; Douglas S Reed; W Paul Duprex
Journal:  PLoS Pathog       Date:  2020-09-18       Impact factor: 6.823

8.  Physiological and immunological changes in the brain associated with lethal eastern equine encephalitis virus in macaques.

Authors:  Joseph R Albe; Henry Ma; Theron H Gilliland; Cynthia M McMillen; Christina L Gardner; Devin A Boyles; Emily L Cottle; Matthew D Dunn; Jeneveve D Lundy; Katherine J O'Malley; Noah Salama; Aaron W Walters; Ivona Pandrea; Tobias Teichert; William B Klimstra; Douglas S Reed; Amy L Hartman
Journal:  PLoS Pathog       Date:  2021-02-03       Impact factor: 6.823

9.  Controlled Heat and Humidity-Based Treatment for the Reuse of Personal Protective Equipment: A Pragmatic Proof-of-Concept to Address the Mass Shortage of Surgical Masks and N95/FFP2 Respirators and to Prevent the SARS-CoV2 Transmission.

Authors:  Louis Bernard; Guillaume Desoubeaux; Elsa Bodier-Montagutelli; Jeoffrey Pardessus; Déborah Brea; Laurine Allimonnier; Sébastien Eymieux; Pierre-Ivan Raynal; Virginie Vasseur; Laurent Vecellio; Ludovic Mathé; Antoine Guillon; Philippe Lanotte; Jérémie Pourchez; Paul O Verhoeven; Stéphane Esnouf; Muriel Ferry; Nicolas Eterradossi; Yannick Blanchard; Paul Brown; Philippe Roingeard; Jean-Pierre Alcaraz; Philippe Cinquin; Mustapha Si-Tahar; Nathalie Heuzé-Vourc'h
Journal:  Front Med (Lausanne)       Date:  2020-10-20

10.  Aerosolization and recovery of viable murine norovirus in an experimental setup.

Authors:  Malin Alsved; Anders Widell; Henrik Dahlin; Sara Karlson; Patrik Medstrand; Jakob Löndahl
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.